Skip to main navigation
Careers
Contact
News
About
Product Pipeline
AZETUKALNER (FOS)
AZETUKALNER (PGTCS)
AZETUKALNER (MDD)
PARTNERED PROGRAMS
PRECLINICAL PROGRAMS
Investors
Header investor menu
Investor Overview
Stock Quote
stock chart
Historic stock lookup
News & Events
Press Releases
Event Calendar
Corporate Governance
Management
BOARD OF DIRECTORS
Committee Composition
FINANCIALS & FILINGS
ANNUAL FINANCIAL REPORTS
Quarterly Results
contact investor relations
Partners
Medical Affairs
Conferences
Publications
Expanded Access Program
About
Product Pipeline
Investors
Partners
Medical Affairs
Careers
Contact
News
Event Details
Topline Results from XEN1101 “X-TOLE” Phase 2b Clinical Trial
October 4, 2021 at 7:30 AM EDT
Supporting Materials
Topline Results from XEN1101 “X-TOLE” Phase 2b Clinical Trial - Presentation
546 KB
Webcast Presentation
Click here for webcast
Event Details
Title
Topline Results from XEN1101 “X-TOLE” Phase 2b Clinical Trial
Date / Time
October 4, 2021 at 7:30 AM EDT
Investor Relations
investor overview
stock quote
stock chart
historic stock lookup
Analyst Coverage
news & events
press releases
events calendar
Corporate Governance
Management
Board of Directors
Committee Composition
financials & filings
annual financial reports
Quarterly Results
contact investor relations
Tools
print page
RSS Feeds
e-mail alerts